| Trial ID: | L6678 |
| Source ID: | NCT00423488
|
| Associated Drug: |
Ezetimibe 10 Mg
|
| Title: |
Ezetimibe and Simvastatin in Primary Hypercholesterolemia, Diabetes Mellitus Type 2, and Coronary Heart Disease (COMPLETED)
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
YES
|
| Results: |
https://ClinicalTrials.gov/show/NCT00423488/results
|
| Conditions: |
Hypercholesterolemia|Diabetes Mellitus, Type 2|Coronary Disease
|
| Interventions: |
DRUG: Ezetimibe 10 mg|DRUG: Simvastatin 20 mg|DRUG: Ezetimibe Placebo|DRUG: Simvastatin 20 mg|DRUG: Simvastatin Placebo
|
| Outcome Measures: |
Primary: Percent Change in Low-Density Lipoprotein Cholesterol (LDL-C) From Baseline to Endpoint, After 6 Weeks of Treatment, 6 weeks of treatment (from Baseline to Endpoint) |
|
| Sponsor/Collaborators: |
Sponsor: Organon and Co | Collaborators: Schering-Plough
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE3
|
| Enrollment: |
93
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2005-07-12
|
| Completion Date: |
2007-02-16
|
| Results First Posted: |
2010-03-09
|
| Last Update Posted: |
2022-02-09
|
| Locations: |
|
| URL: |
https://clinicaltrials.gov/show/NCT00423488
|
